Summary

Hormone Replacement Therapy Market – Scope of Report
TMR’s report on the global hormone replacement therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hormone replacement therapy market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hormone replacement therapy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hormone replacement therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hormone replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hormone replacement therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hormone replacement therapy market.

The report delves into the competitive landscape of the global hormone replacement therapy market. Key players operating in the global hormone replacement therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hormone replacement therapy market profiled in this report.

Key Questions Answered in Global hormone replacement therapy Market Report
• What is the sales/revenue generated by hormone replacement therapy across all regions during the forecast period?
• What are the opportunities in the global hormone replacement therapy market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Hormone Replacement Therapy Market – Research Objectives and Research Approach
The comprehensive report on the global hormone replacement therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hormone replacement therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hormone replacement therapy market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hormone Replacement Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hormone Replacement Therapy Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Hormone Replacement Therapy Market Analysis and Forecast, by Treatment Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2020-2034
6.3.1. Human Growth Hormone (HGH) Replacement Therapy
6.3.2. Thyroid Replacement Therapy
6.3.3. Testosterone Replacement Therapy
6.3.4. Dopamine Agonist
6.3.5. Somatostatin Analogue
6.3.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
6.4. Market Attractiveness, by Treatment Type
7. Global Hormone Replacement Therapy Market Analysis and Forecast, by Route of Administration
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Route of Administration, 2020-2034
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Transdermal
7.4. Market Attractiveness, by Route of Administration
8. Global Hormone Replacement Therapy Market Analysis and Forecast, by Disease Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Disease Indication, 2020-2034
8.3.1. Menopause
8.3.2. Hypothyroidism
8.3.3. Male Hypogonadism
8.3.4. Growth Hormone Deficiency
8.3.5. Hypoparathyroidism
8.4. Market Attractiveness, by Disease Indication
9. Global Hormone Replacement Therapy Market Analysis and Forecast, by Distribution Channel
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Distribution Channel, 2020-2034
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness, by Distribution Channel
10. Global Hormone Replacement Therapy Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Hormone Replacement Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2020-2034
11.2.1. Human Growth Hormone (HGH) Replacement Therapy
11.2.2. Thyroid Replacement Therapy
11.2.3. Testosterone Replacement Therapy
11.2.4. Dopamine Agonist
11.2.5. Somatostatin Analogue
11.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
11.3. Market Attractiveness, by Treatment Type
11.4. Market Value Forecast, by Route of Administration, 2020-2034
11.4.1. Oral
11.4.2. Parenteral
11.4.3. Transdermal
11.5. Market Attractiveness, by Route of Administration
11.6. Market Value Forecast, by Disease Indication, 2020-2034
11.6.1. Menopause
11.6.2. Hypothyroidism
11.6.3. Male Hypogonadism
11.6.4. Growth Hormone Deficiency
11.6.5. Hypoparathyroidism
11.7. Market Attractiveness, by Disease Indication
11.8. Market Value Forecast, by Distribution Channel, 2020-2034
11.8.1. Hospital Pharmacies
11.8.2. Retail Pharmacies
11.8.3. Online Pharmacies
11.9. Market Attractiveness, by Distribution Channel
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Treatment Type
11.11.2. By Route of Administration
11.11.3. By Disease Indication
11.11.4. By Distribution Channel
11.11.5. By Country
12. Europe Hormone Replacement Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2020-2034
12.2.1. Human Growth Hormone (HGH) Replacement Therapy
12.2.2. Thyroid Replacement Therapy
12.2.3. Testosterone Replacement Therapy
12.2.4. Dopamine Agonist
12.2.5. Somatostatin Analogue
12.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
12.3. Market Attractiveness, by Treatment Type
12.4. Market Value Forecast, by Route of Administration, 2020-2034
12.4.1. Oral
12.4.2. Parenteral
12.4.3. Transdermal
12.5. Market Attractiveness, by Route of Administration
12.6. Market Value Forecast, by Disease Indication, 2020-2034
12.6.1. Menopause
12.6.2. Hypothyroidism
12.6.3. Male Hypogonadism
12.6.4. Growth Hormone Deficiency
12.6.5. Hypoparathyroidism
12.7. Market Attractiveness, by Disease Indication
12.8. Market Value Forecast, by Distribution Channel, 2020-2034
12.8.1. Hospital Pharmacies
12.8.2. Retail Pharmacies
12.8.3. Online Pharmacies
12.9. Market Attractiveness, by Distribution Channel
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Treatment Type
12.11.2. By Route of Administration
12.11.3. By Disease Indication
12.11.4. By Distribution Channel
12.11.5. By Country/Sub-region
13. Asia Pacific Hormone Replacement Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment Type, 2020-2034
13.2.1. Human Growth Hormone (HGH) Replacement Therapy
13.2.2. Thyroid Replacement Therapy
13.2.3. Testosterone Replacement Therapy
13.2.4. Dopamine Agonist
13.2.5. Somatostatin Analogue
13.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
13.3. Market Attractiveness, by Treatment Type
13.4. Market Value Forecast, by Route of Administration, 2020-2034
13.4.1. Oral
13.4.2. Parenteral
13.4.3. Transdermal
13.5. Market Attractiveness, by Route of Administration
13.6. Market Value Forecast, by Disease Indication, 2020-2034
13.6.1. Menopause
13.6.2. Hypothyroidism
13.6.3. Male Hypogonadism
13.6.4. Growth Hormone Deficiency
13.6.5. Hypoparathyroidism
13.7. Market Attractiveness, by Disease Indication
13.8. Market Value Forecast, by Distribution Channel, 2020-2034
13.8.1. Hospital Pharmacies
13.8.2. Retail Pharmacies
13.8.3. Online Pharmacies
13.9. Market Attractiveness, by Distribution Channel
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Treatment Type
13.11.2. By Route of Administration
13.11.3. By Disease Indication
13.11.4. By Distribution Channel
13.11.5. By Country/Sub-region
14. Latin America Hormone Replacement Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment Type, 2020-2034
14.2.1. Human Growth Hormone (HGH) Replacement Therapy
14.2.2. Thyroid Replacement Therapy
14.2.3. Testosterone Replacement Therapy
14.2.4. Dopamine Agonist
14.2.5. Somatostatin Analogue
14.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
14.3. Market Attractiveness, by Treatment Type
14.4. Market Value Forecast, by Route of Administration, 2020-2034
14.4.1. Oral
14.4.2. Parenteral
14.4.3. Transdermal
14.5. Market Attractiveness, by Route of Administration
14.6. Market Value Forecast, by Disease Indication, 2020-2034
14.6.1. Menopause
14.6.2. Hypothyroidism
14.6.3. Male Hypogonadism
14.6.4. Growth Hormone Deficiency
14.6.5. Hypoparathyroidism
14.7. Market Attractiveness, by Disease Indication
14.8. Market Value Forecast, by Distribution Channel, 2020-2034
14.8.1. Hospital Pharmacies
14.8.2. Retail Pharmacies
14.8.3. Online Pharmacies
14.9. Market Attractiveness, by Distribution Channel
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Treatment Type
14.11.2. By Route of Administration
14.11.3. By Disease Indication
14.11.4. By Distribution Channel
14.11.5. By Country/Sub-region
15. Middle East & Africa Hormone Replacement Therapy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Treatment Type, 2020-2034
15.2.1. Human Growth Hormone (HGH) Replacement Therapy
15.2.2. Thyroid Replacement Therapy
15.2.3. Testosterone Replacement Therapy
15.2.4. Dopamine Agonist
15.2.5. Somatostatin Analogue
15.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
15.3. Market Attractiveness, by Treatment Type
15.4. Market Value Forecast, by Route of Administration, 2020-2034
15.4.1. Oral
15.4.2. Parenteral
15.4.3. Transdermal
15.5. Market Attractiveness, by Route of Administration
15.6. Market Value Forecast, by Disease Indication, 2020-2034
15.6.1. Menopause
15.6.2. Hypothyroidism
15.6.3. Male Hypogonadism
15.6.4. Growth Hormone Deficiency
15.6.5. Hypoparathyroidism
15.7. Market Attractiveness, by Disease Indication
15.8. Market Value Forecast, by Distribution Channel, 2020-2034
15.8.1. Hospital Pharmacies
15.8.2. Retail Pharmacies
15.8.3. Online Pharmacies
15.9. Market Attractiveness, by Distribution Channel
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Treatment Type
15.11.2. By Route of Administration
15.11.3. By Disease Indication
15.11.4. By Distribution Channel
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Novartis AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Abbott Laboratories
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Mylan N.V.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck & Co., Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Bayer AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Pfizer Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Novo Nordisk A/S
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. QuatRx Pharmaceuticals Co.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Amgen Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Eli, Lilly and Company
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. AbbVie Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Noven Pharmaceuticals
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview